Validation and public health modelling of risk prediction models for kidney cancer using the UK Biobank

5Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: To externally validate risk models for the detection of kidney cancer, as early detection of kidney cancer improves survival and stratifying the population using risk models could enable an individually tailored screening programme. Methods: We validated the performance of 30 existing phenotypic models predicting the risk of kidney cancer in the UK Biobank cohort (n = 450 687). We compared the discrimination and calibration of models for men, women, and a mixed-sex cohort. Population level data were used to estimate model performance in a screening scenario for a range of risk thresholds (6-year risk: 0.1–1.0%). Results: In all, 10 models had reasonable discrimination (area under the receiver-operating characteristic curve >0.60), although some had poor calibration. Modelling demonstrated similar performance of the best models over a range of thresholds. The models showed an improvement in ability to identify cases compared to age- and sex-based screening. All the models performed less well in women than men. Conclusions: The present study is the first comprehensive external validation of risk models for kidney cancer. The best-performing models are better at identifying individuals at high risk of kidney cancer than age and sex alone; however, the benefits are relatively small. Feasibility studies are required to determine applicability to a screening programme.

References Powered by Scopus

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

66856Citations
N/AReaders
Get full text

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

5702Citations
N/AReaders
Get full text

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants with Those of the General Population

2205Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes

28Citations
N/AReaders
Get full text

The current state of genetic risk models for the development of kidney cancer: a review and validation

8Citations
N/AReaders
Get full text

Risk-stratified screening for the early detection of kidney cancer

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Harrison, H., Pennells, L., Wood, A., Rossi, S. H., Stewart, G. D., Griffin, S. J., & Usher-Smith, J. A. (2022). Validation and public health modelling of risk prediction models for kidney cancer using the UK Biobank. BJU International, 129(4), 498–511. https://doi.org/10.1111/bju.15598

Readers' Seniority

Tooltip

Researcher 2

50%

Professor / Associate Prof. 1

25%

PhD / Post grad / Masters / Doc 1

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

80%

Psychology 1

20%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free